TheStreet Lowers Vitamin Shoppe, Inc (NYSE:VSI) to D

TheStreet cut shares of Vitamin Shoppe, Inc (NYSE:VSI) from a c- rating to a d rating in a research note released on Wednesday morning.

Other analysts also recently issued reports about the company. Barclays PLC restated an equal weight rating and issued a $13.00 target price (down from $24.00) on shares of Vitamin Shoppe in a research note on Sunday, May 14th. Morgan Stanley upgraded Vitamin Shoppe from an underweight rating to an equal weight rating and set a $14.00 target price for the company in a research note on Thursday, May 11th. Zacks Investment Research upgraded Vitamin Shoppe from a strong sell rating to a hold rating in a research note on Tuesday, July 18th. ValuEngine downgraded Vitamin Shoppe from a buy rating to a hold rating in a research note on Friday, June 2nd. Finally, Deutsche Bank AG restated a hold rating and issued a $7.00 target price (down from $14.00) on shares of Vitamin Shoppe in a research note on Thursday. Two investment analysts have rated the stock with a sell rating and eight have given a hold rating to the stock. The company currently has a consensus rating of Hold and an average price target of $15.71.

Shares of Vitamin Shoppe (NYSE VSI) opened at 6.20 on Wednesday. Vitamin Shoppe has a one year low of $5.75 and a one year high of $28.56. The company’s market capitalization is $144.03 million. The stock has a 50 day moving average price of $10.47 and a 200-day moving average price of $15.91.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.39 by $0.16. The business had revenue of $304.84 million for the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The business’s revenue was down 8.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.55 earnings per share. On average, equities research analysts expect that Vitamin Shoppe will post $0.98 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This report was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://stocknewstimes.com/2017/08/12/thestreet-lowers-vitamin-shoppe-inc-nysevsi-to-d.html.

Institutional investors have recently made changes to their positions in the stock. Arizona State Retirement System boosted its position in shares of Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock valued at $249,000 after buying an additional 100 shares during the last quarter. Texas Permanent School Fund boosted its position in shares of Vitamin Shoppe by 0.8% in the second quarter. Texas Permanent School Fund now owns 17,389 shares of the specialty retailer’s stock valued at $203,000 after buying an additional 145 shares during the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares during the last quarter. Mason Street Advisors LLC boosted its position in shares of Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares during the last quarter. Finally, Capstone Asset Management Co. boosted its position in shares of Vitamin Shoppe by 3.5% in the second quarter. Capstone Asset Management Co. now owns 14,040 shares of the specialty retailer’s stock valued at $164,000 after buying an additional 470 shares during the last quarter.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply